Sihuan (460 HK) Updates on Audit Delay: Improper accounting treatment in consolidation trick of using MRAs (Market Research Agents) to exclude hidden sales and distribution expenses to artificially boost profits April 20, 2015April 20, 2015bambooinnovator Leave a comment Related postings: Late audits halt trading in Morgan Stanley-backed stocks Tianhe Chemicals (1619 HK) and Sihuan Pharmaceutical (460 HK) Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Click to print (Opens in new window) Print Click to email a link to a friend (Opens in new window) Email Like Loading... Related
AsianExtractor: Unearthing Accounting Fraud in Asia 